As reported previously, IFS has since 2002 been involved in a legal dispute concerning the partly-owned company IFS Sri Lanka. In October 2012, the counterparty in the dispute initiated arbitration proceedings against IFS with the Singapore International Arbitration Centre, on the basis of a shareholders’ agreement between the parties. In the arbitration proceedings, the counterparty initially claimed compensation for damages in the amount of US$ 76 million including interest. However, the claim was later revised upwards. The revised claim was unspecified but could be understood to mean that IFS’ half-owned company IFS Sri Lanka be paid an amount in the range of US$ 237–535 million including interest, and that an unspecified amount be distributed as dividends to the owners. Since the beginning of the legal dispute, IFS has deemed the counterparty’s allegations as completely unsubstantiated and without any merit and the claims raised in the arbitration proceedings have been rejected by IFS in their entirety as being frivolous and completely unmeritorious and unfounded. The arbitral tribunal’s Final Award was received by IFS on June 20, 2014. In the Final Award, the counterparty’s claims have been completely rejected and it is declared that IFS did not breach the shareholders’ agreement as alleged by the counterparty. The counterparty has also been ordered to pay for the main part of the fees of the arbitral tribunal and a substantial portion of IFS’ legal costs in the proceedings. Contact Information Alastair Sorbie, President and CEO. Telephone: 44 1494 42 89 00, press@ifsworld.com Jesper Alwall, General Counsel, Corporate Legal Affairs. Telephone: 46 8 58 78 45 00, press@ifsworld.com About IFS IFS (http://www.ifsworld.com/en/)™ is a globally recognized leader in developing and delivering business software for enterprise resource planning (ERP), enterprise asset management (EAM) and enterprise service management (ESM). IFS brings customers in targeted sectors closer to their business, helps them be more agile and enables them to profit from change. IFS is a public company (XSTO: IFS) that was founded in 1983 and currently has over 2,600 employees. IFS supports more than 2,200 customers worldwide from local offices and through partners in more than 60 countries. For more information visit: www.ifsworld.com. Follow us on Twitter: @ifsworld (http://twitter.com/ifsworld) Visit the IFS Blogs on technology, innovation and creativity: http://blogs.ifsworld.com/ IFS discloses the information provided herein pursuant to the Financial Instruments Trading Act (1991:980) and/or the Securities Markets Act (2007:528). The information was submitted for publication on June 23, 2014 at 8 a.m. (CEST).
Final Award in the IFS Sri Lanka legal dispute As reported
Top 10 Most Recent News Articles
WeaveGrid Powers EVConnectNC: Charging Incentives Launched
Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...
Continue Reading
Novo's Research Unlocks New Insights into Food Noise
Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....
Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List
A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...
Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices
Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...
Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era
The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...
Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes
Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....
Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West
Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...
Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results
Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...
Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale
Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...
Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion
Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...
Continue ReadingTop 5 Most Recently Viewed Articles
Explore Rob Zombie's Unique Art Exhibition in Kent Connetcticut
Rob Zombie's Art Exhibition: "What Lurks on Channel X?" Morrison Gallery is excited to announce the first-ever exhibition of Rob Zombie's provocative artwork titled "What Lurks on Channel X?" This unique showcase celebrates the artistry of the renowned rock musician and filmmaker. The exhibition is set to open for public viewing, bringing an array of Zombie's dynamic...
Continue Reading
Unlocking Over $11M Annually: Modernizing Industrial Systems
Revolutionizing Industrial Automation for Greater Savings Modernization is key for industrial companies seeking to thrive, especially in today’s competitive landscape. A recent enlightening study has unveiled a significant opportunity: organizations can potentially reclaim $11.28 million annually by shifting away from outdated closed automation systems. This information...
Continue Reading
Investors on Alert: Security Class Action for StubHub Holdings
Investors on Alert: Security Class Action for StubHub Holdings National shareholder rights firm Hagens Berman is reaching out to investors of StubHub Holdings, Inc. (NYSE: STUB) following news of a significant deadline in a prospective securities class action. This legal inquiry focuses on whether the Initial Public Offering (IPO) documents from StubHub, made available to...
Continue Reading
Melexis Enhances Shareholder Value with Strategic Buyback
Melexis Enhances Shareholder Value with Strategic Buyback Melexis continues to demonstrate its commitment to enhancing shareholder value with an active share buy-back program. Following the announcement made late last year regarding the initiation of this program, the company recently announced the purchase of 47,500 shares on Euronext Brussels during a specified period...
Continue Reading
John Manimas Unveils Breakthrough in Ancient Geometry Puzzle
The Remarkable Discovery of John Manimas John Manimas, renowned for his engaging exploration of mathematical mysteries, has recently announced a significant advancement in the realm of geometry. He claims to have discovered a positive solution to the age-old Pythagorean riddle: the question of whether one can construct a circle that is exactly equal in area to a given...
Continue Reading